ExodusPoint Capital Management’s Adicet Bio ACET Stock Holding History

ExodusPoint Capital Management’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,456	Closed	-$134K	–	1799
2023 Q1	$134K	Buy	+1,456	New	+$183K	﹤0.01%	1609
2021 Q2	–	Sell	-4,480	Closed	-$938K	–	2274
2021 Q1	$938K	Buy	4,480 +1,516	+51%	+$348K	0.01%	952
2020 Q4	$666K	Buy	+2,964	New	+$607K	0.01%	1077

Other funds holding ACET

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

ExodusPoint Capital Management's ACET Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 1,456 shares — an estimated $134K sold.

ExodusPoint Capital Management first reported a position in ACET in Q4 2020 and held it in 3 quarters. The position peaked at $938K in Q1 2021. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

ExodusPoint Capital Management reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 1,456 Adicet Bio shares in Q2 2023, an estimated $134K.
ExodusPoint Capital Management first reported a position in Adicet Bio in Q4 2020 and held it in 3 quarters.
ExodusPoint Capital Management's Adicet Bio position peaked at $938K in Q1 2021.
94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.